Clinical Trial Update: Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two post-exposure prophylaxis regimens for HIV-1 (tenofovir/emtricitabine with lopinavir/ritonavir versus tenofovir/emtricitabine with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine (Emtricitabine)
• Lopinavir/ritonavir (lopinavir/ritonavir)
• Raltegravir (raltegravir)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infection | Phase 4 | Status: COMPLETED